| Literature DB >> 30337841 |
J M Rosa-Rosa1, T Caniego-Casas2, S Leskela1,2, G Muñoz2, F Del Castillo2,3,4, P Garrido2,5,6, J Palacios1,2,6,7.
Abstract
BACKGROUND: Personalised medicine is nowadays a major objective in oncology. Molecular characterization of tumours through NGS offers the possibility to find possible therapeutic targets in a time- and cost-effective way. However, the low quality and complexity of FFPE DNA samples bring a series of disadvantages for massive parallel sequencing techniques compared to high-quality DNA samples (from blood cells, cell cultures, etc.).Entities:
Keywords: FFPE samples; NGS; Optimization; Protocol; SureSelectQXT
Year: 2018 PMID: 30337841 PMCID: PMC6182866 DOI: 10.1186/s12575-018-0084-7
Source DB: PubMed Journal: Biol Proced Online ISSN: 1480-9222 Impact factor: 3.244
Fig. 1Quality and integrity of the 9 DNA samples with the Agilent 2200 Tape Station and Genomic DNA Screen Tape. a Genomic DNA samples. b Digested, amplified and purified DNA samples
Fig. 2Quantification and qualification of library DNA with the Agilent 2200 Tape station and D1000 Screen Tape using 50 (1), 150 (2) and 500 (3) ng of DNA input. a Gel image. b Electropherogram. c Table with library concentration estimations
Fig. 3Quantification and qualification of library DNA with the Agilent 2200 Tape station and D1000 Screen Tape using 8 (1) or 10 (2) cycles during pre-hybridization PCR. a Gel image. b Electropherogram. c Table with library concentration estimations
Results from the first sequencing run
| Sample | DIN | #Pre-hyb Cycles | Hyb Input (ng) | #Sequences | Aligned | On target | No PCR Dup | Final | MedianDepth (per million reads) |
|---|---|---|---|---|---|---|---|---|---|
| NA12878 | 9.3 | 8 | 750 | 3,387,238 | 99.37% | 75.07% | 48.16% | 48.14% | 113.07 |
| NA12891 | 9.1 | 8 | 750 | 3,188,127 | 99.48% | 72.49% | 49.56% | 49.54% | 118.25 |
| NA12892 | 9.1 | 8 | 750 | 3,115,861 | 98.88% | 73.80% | 50.41% | 50.40% | 119.07 |
| NT1 | 6.4 | 8 | 401 | 11,305,259 | 99.72% | 71.49% | 31.15% | 31.13% | 63.42 |
| T1 | 2.7 | 10 | 362.5 | 2,866,206 | 99.37% | 72.20% | 35.17% | 35.13% | 66.29 |
| T2 | 2.2 | 10 | 11,9 | 2,813,675 | 97.65% | 81.07% | 4.45% | 4.40% | 4.98 |
| T3 | 3 | 10 | 87 | 2,730,937 | 99.39% | 77.30% | 13.86% | 13.84% | 25.63 |
| T4 | 2 | 10 | 12 | 2,347,778 | 97.87% | 71.73% | 5.09% | 5.05% | 7.24 |
| T5 | 3.6 | 10 | 32.4 | 3,077,225 | 99.35% | 79.63% | 8.45% | 8.42% | 13.65 |
| NA12892 | 9.1 | 10 | 156 | 2,983,904 | 98.63% | 77.31% | 49.21% | 49.19% | 106.24 |
From left to right: sample name, DIN value for input DNA, number of cycles in the pre-hyb PCR, total amount of digested and adaptor-tagged library used in the hybridization step, number of sequences obtained, percentage of sequences aligned to the human reference genome, percentage of sequences on target, percentage of sequences after PCR duplicates removal, percentage of sequences after low-quality-mapped-reads removal, median of the depth in the target regions obtained per million reads (normalized for a more realistic comparison)
Fig. 4Gel image of NA12892, NT1 and T1 pre-hyb products with the Agilent 2200 Tape station and D1000 Screen Tape. Input DNA was 50 ng. a Using standard reagent volumes. b Using ½x standard reagent volumes
Fig. 5Pre-hyb library quantification using the Agilent 2200 Tape station and D1000 Screen Tape. a Gel image showing library products where digestion times were set up at 1, 2, 3, 4, 5 and the standard 10 min. b Graphical representation of pre-hyb library concentration vs. digestion times. c Gel image of different DNA input and digestion time tests. b DNA input and digestion time conditions and pre-hyb concentration
Global results from the 3 sequencing runs
From left to right: sample name, reagent volume (1× = standard, 1/2× = half standard), digestion time, number of cycles in pre-hyb PCR, volume of probe (1× = standard, 1/2× = half standard, 1/4× = quarter standard), number of cycles in post-hyb PCR, pre-hyb library concentration, post-hyb library concentration, number of sequences obtained, percentage of sequences aligned to human reference genome, percentage of sequences on target, percentage of sequences after PCR duplicates removal, percentage of sequences after low-quality-mapped-reads removal, median of the depth in target regions per million reads (normalized value for comparison). In orange, results for sample NA12892 highlighting that no negative impact was noticeable after modifications of the protocol in high-quality DNA samples. In green, improved results obtained for a high-quality FFPE sample (NT1) with some of the modification. In blue, results for sample T1 with notable improvement obtained after modifications. In red and bold, improved results for two very low-quality FFPE samples (T3 and T5) after modifications in the protocol
Fig. 6Correlations. a Correlation between post-hyb concentration measured by QPCR and DIN value for all samples. b Correlation between post-hyb concentration measured by QPCR and DIN value for FFPE samples. c Correlation between post-hyb concentration measured by QPCR and qcPCR concentration measured with Tape Station for FFPE samples. d Correlation between post-hyb concentration and qcPCR concentration measured, both with Tape Station, for FFPE samples
Descriptive of samples used for the validation of the qcPCR for FFPE DNA samples
From left to right: samples ID, DIN value, concentration of the PCR checkpoint, pre-hyb concentration, post-hyb concentration measured by Tape Station and QPCR. Highlighted in red those samples which would have been ruled out according to the checkpoint. Highlighted in blue a borderline sample